AI assistant
AbbVie Inc. — Director's Dealing 2013
Feb 19, 2013
29755_dirs_2013-02-19_e7b53d87-7a7b-4983-8d8a-28a63a23e3a2.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AbbVie Inc. (ABBV)
CIK: 0001551152
Period of Report: 2013-02-14
Reporting Person: GONZALEZ RICHARD A (Chairman of the Board and CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-02-14 | Common stock, $0.01 par value | A | 257720 | $0.00 | Acquired | 307152 | Direct |
| 2013-02-19 | Common stock, $0.01 par value | F | 3130 | $37.58 | Disposed | 304022 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2013-02-14 | Option (right to buy) | $35.88 | A | 526430 | Acquired | 2023-02-13 | Common stock (526430) | Direct |
Footnotes
F1: These securities represent performance vested restricted stock awards under the AbbVie 2013 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon AbbVie reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes.
F2: Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.The option becomes exerciseable in annual increments of 175,477 on 02/14/2014, 175,476 on 02/14/2015, and 175,477 on 02/14/2016.